Your browser doesn't support javascript.
loading
Combination of common and novel rare NUDT15 variants improves predictive sensitivity of thiopurine-induced leukopenia in children with acute lymphoblastic leukemia.
Zhu, Yiping; Yin, Dandan; Su, Yali; Xia, Xuyang; Moriyama, Takaya; Nishii, Rina; Liao, Fei; Zhang, Shouyue; Guo, Xia; Hou, Qianqian; Ai, Yuan; Zhou, Xueyan; Sun, Shuwen; Zhang, Duyu; Zhang, Yan; Lin, Chao; Deng, Yiqi; Lu, Xiaoxi; Wang, Yuelan; Ma, Zhigui; Wang, Heyao; Liu, Bo; Yang, Li; Zhang, Wei; Yang, Jun J; Shu, Yang; Gao, Ju; Xu, Heng.
Afiliação
  • Zhu Y; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Yin D; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Su Y; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Xia X; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Moriyama T; Department of Pharmaceutical Sciences and Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Nishii R; Department of Pharmaceutical Sciences and Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Liao F; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Zhang S; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Guo X; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Hou Q; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Ai Y; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Zhou X; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Sun S; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Zhang D; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Zhang Y; Department of Thoracic Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Lin C; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Deng Y; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Lu X; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Wang Y; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Ma Z; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China.
  • Wang H; Department of Precision Medicine, China-Japan Friendship Hospital, Beijing, China.
  • Liu B; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Yang L; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
  • Zhang W; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, China.
  • Yang JJ; Department of Pharmaceutical Sciences and Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Shu Y; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China xuheng81916@scu.edu.cn gaoju651220@126.com shuyang19
  • Gao J; Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, China xuheng81916@scu.edu.cn gaoju651220@126.com shuyang1986@gmail.com.
  • Xu H; Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China xuheng81916@scu.edu.cn gaoju651220@126.com shuyang19
Haematologica ; 103(7): e293-e295, 2018 07.
Article em En | MEDLINE | ID: mdl-29519865
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirofosfatases / Variação Genética / Leucemia-Linfoma Linfoblástico de Células Precursoras / Variantes Farmacogenômicos / Leucopenia / Mercaptopurina Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirofosfatases / Variação Genética / Leucemia-Linfoma Linfoblástico de Células Precursoras / Variantes Farmacogenômicos / Leucopenia / Mercaptopurina Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article